By: ICN Bureau
Last updated : July 31, 2021 9:49 am
The Chemicals Technology Group (CTG) of SRF Limited is actively engaged in the development of new process technologies and focuses on high end molecules
SRF Limited, a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates, has taken the tally of global patents to 99.
In Q1 FY22, 8 new patents were granted taking the overall tally to 99 patents till date. Overall, the company has applied for 317 patents.
The Chemicals Technology Group (CTG) of SRF Limited is actively engaged in the development of new process technologies and focuses on high end molecules. The company is moving up the value chain by accelerating qualifications of new molecules in both agro and pharmaceuticals sectors and capacity utilization of newly commissioned plants to remain in focus.
The company has established relationships with marquee customers with capability in scaling up pilot processes and creating value through operational excellence and high levels of customer engagement backed by strong R&D, technical service, product, and quality management under one roof.
The company is also handling complex reactions like halogenation, ethylation, hydrogenation, nitration, diazotization, grignard, isomerization, amination, organocatalysis, and decarboxylation.
Equipped with three state-of-the-art R&D centres in India, the company has an ingenious team of scientists and engineers with strong competencies and capabilities.
Established in 1970, SRF Limited has a diversified business portfolio covering Fluorochemicals, Specialty Chemicals, Packaging Films, Technical Textiles and Coated and Laminated Fabrics. Anchored by a strong workforce of close to 7,000 employees from different nationalities working across eleven manufacturing plants in India and one each in Thailand, South Africa and Hungary, the company exports to more than 75 countries.